Aptamer Binding Assay for the E Antigen of Hepatitis B Using Modified Aptamers with G-Quadruplex Structures
Open Access
- 6 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (9), 6495-6501
- https://doi.org/10.1021/acs.analchem.9b05740
Abstract
The E antigen of hepatitis B (HBeAg) is positively associated with an increased risk of developing liver cancer and cirrhosis in chronic hepatitis B (CHB) patients. Clinical monitoring of HBeAg provides guidance to the treatment of CHB and the assessment of disease progression. We describe here an affinity binding assay for HBeAg, which takes advantage of G-quadruplex aptamers for enhanced binding and stability. We demonstrate a strategy to improve the binding affinity of aptamers by modifying their sequences upon their G-quadruplex and secondary structures. On the basis of predicting a stable G-quadruplex and a secondary structure, we truncated 19 nucleotides (nt) from the primer regions of an 80-nt aptamer; and the resulting 61-nt aptamer enhanced binding affinity by 19 times (Kd = 1.2 nM). We mutated a second aptamer (40 nt) in one loop region and incorporated pyrrolo-deoxycytidine to replace deoxycytidine in another loop. The modified 40-nt aptamer, with a stable G-quadruplex and two modified loops, exhibited 100 times higher binding affinity for HBeAg (Kd = 0.4 nM) than the unmodified original aptamer. Using the two newly modified aptamers, one serving as the capture and the other as the reporter, we have developed an improved sandwich binding assay for HBeAg. Analyses of HBeAg in serum samples (concentration ranging from 0.1 to 60 ng/mL) of ten hepatitis B patients, showing consistent results with clinical tests, demonstrate a successful application of the aptamer modification strategy and the associated aptamer binding assay.Keywords
Funding Information
- Canadian Institutes of Health Research
- Canada Research Chairs
- Alberta Health
- Natural Sciences and Engineering Research Council of Canada
- Alberta Innovates
- Li Ka Shing Institute of Virology, University of Alberta
This publication has 33 references indexed in Scilit:
- Chronic Hepatitis B InfectionJAMA, 2018
- Antigenic Switching of Hepatitis B Virus by Alternative Dimerization of the Capsid ProteinStructure, 2013
- Methods for measuring aptamer-protein equilibria: A reviewAnalytica Chimica Acta, 2010
- Applications of Aptamers as SensorsAnnual Review of Analytical Chemistry, 2009
- HBeAg seroconversion as an important end point in the treatment of chronic hepatitis BHepatology International, 2009
- Aptamer-Facilitated Biomarker Discovery (AptaBiD)Journal of the American Chemical Society, 2008
- Chronic hepatitis BHepatology, 2007
- Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA)Journal of Pharmaceutical and Biomedical Analysis, 2004
- Designed Signaling Aptamers that Transduce Molecular Recognition to Changes in Fluorescence IntensityJournal of the American Chemical Society, 2000
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971